rs1006737
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000719.7(CACNA1C):c.477+115699G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 152,038 control chromosomes in the GnomAD database, including 10,258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain risk allele (no stars).
Frequency
Genomes: 𝑓 0.35 ( 10258 hom., cov: 32)
Consequence
CACNA1C
NM_000719.7 intron
NM_000719.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.248
Publications
309 publications found
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | ENST00000399603.6 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
| CACNA1C | ENST00000399655.6 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
| CACNA1C | ENST00000682544.1 | c.567+115699G>A | intron_variant | Intron 3 of 49 | ENSP00000507184.1 | |||||
| CACNA1C | ENST00000406454.8 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 5 | ENSP00000385896.3 | ||||
| CACNA1C | ENST00000399634.6 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 5 | ENSP00000382542.2 | ||||
| CACNA1C | ENST00000683824.1 | c.567+115699G>A | intron_variant | Intron 3 of 47 | ENSP00000507867.1 | |||||
| CACNA1C | ENST00000347598.9 | c.477+115699G>A | intron_variant | Intron 3 of 48 | 1 | ENSP00000266376.6 | ||||
| CACNA1C | ENST00000344100.7 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000341092.3 | ||||
| CACNA1C | ENST00000327702.12 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 1 | ENSP00000329877.7 | ||||
| CACNA1C | ENST00000399617.6 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 5 | ENSP00000382526.1 | ||||
| CACNA1C | ENST00000682462.1 | c.567+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507105.1 | |||||
| CACNA1C | ENST00000683781.1 | c.567+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507434.1 | |||||
| CACNA1C | ENST00000683840.1 | c.567+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507612.1 | |||||
| CACNA1C | ENST00000683956.1 | c.567+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000506882.1 | |||||
| CACNA1C | ENST00000399638.5 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 1 | ENSP00000382547.1 | ||||
| CACNA1C | ENST00000335762.10 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 5 | ENSP00000336982.5 | ||||
| CACNA1C | ENST00000399606.5 | c.477+115699G>A | intron_variant | Intron 3 of 47 | 1 | ENSP00000382515.1 | ||||
| CACNA1C | ENST00000399621.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382530.1 | ||||
| CACNA1C | ENST00000399637.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382546.1 | ||||
| CACNA1C | ENST00000402845.7 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000385724.3 | ||||
| CACNA1C | ENST00000399629.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382537.1 | ||||
| CACNA1C | ENST00000682336.1 | c.477+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507898.1 | |||||
| CACNA1C | ENST00000399591.5 | c.477+115699G>A | intron_variant | Intron 3 of 45 | 1 | ENSP00000382500.1 | ||||
| CACNA1C | ENST00000399595.5 | c.477+115699G>A | intron_variant | Intron 3 of 45 | 1 | ENSP00000382504.1 | ||||
| CACNA1C | ENST00000399649.5 | c.477+115699G>A | intron_variant | Intron 3 of 45 | 1 | ENSP00000382557.1 | ||||
| CACNA1C | ENST00000399597.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382506.1 | ||||
| CACNA1C | ENST00000399601.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382510.1 | ||||
| CACNA1C | ENST00000399641.6 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382549.1 | ||||
| CACNA1C | ENST00000399644.5 | c.477+115699G>A | intron_variant | Intron 3 of 46 | 1 | ENSP00000382552.1 | ||||
| CACNA1C | ENST00000682835.1 | c.477+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507282.1 | |||||
| CACNA1C | ENST00000683482.1 | c.477+115699G>A | intron_variant | Intron 3 of 46 | ENSP00000507169.1 | |||||
| CACNA1C | ENST00000682686.1 | c.477+115699G>A | intron_variant | Intron 3 of 45 | ENSP00000507309.1 | |||||
| CACNA1C | ENST00000682152.1 | c.426+115699G>A | intron_variant | Intron 2 of 5 | ENSP00000506759.1 | |||||
| CACNA1C | ENST00000480911.6 | n.477+115699G>A | intron_variant | Intron 3 of 26 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53833AN: 151920Hom.: 10263 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
53833
AN:
151920
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.354 AC: 53869AN: 152038Hom.: 10258 Cov.: 32 AF XY: 0.349 AC XY: 25918AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
53869
AN:
152038
Hom.:
Cov.:
32
AF XY:
AC XY:
25918
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
19845
AN:
41450
American (AMR)
AF:
AC:
4366
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1027
AN:
3468
East Asian (EAS)
AF:
AC:
266
AN:
5178
South Asian (SAS)
AF:
AC:
1192
AN:
4818
European-Finnish (FIN)
AF:
AC:
3363
AN:
10560
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22771
AN:
67966
Other (OTH)
AF:
AC:
681
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1740
3480
5220
6960
8700
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
527
AN:
3478
ClinVar
Significance: Uncertain risk allele
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Post-traumatic stress disorder Other:1
-
Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry
Significance:Uncertain risk allele
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.